Most discontinued anti-tau antibodies (red) targeted tau’s N-terminus. Of the antibodies currently in trials (green), bepranemab and E2814 presented results at CTAD, while JJ-63733657/posdinemab and ...

She studied the dynamic changes within the MM-TME of an immunocompetent MM mouse ... and human samples, and in the MM mouse ...

An FDA-approved vaccine for smallpox and mpox is effective but causes side effects. The other requires multiple doses. An experimental single-dose vaccine uses the horsepox virus to harness the ...

Researchers have identified new roles for a protein long known to protect against severe flu infection—among them, raising ...

Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

Net loss from continuing operations was $ (20.5) million and $ (38.9) million for the three and nine months ended September 30, 2024, respectively, compared to $ (8.2) million and $ (45.3) million for ...